Skip to content
Home/Companies/TMT/Nereus Pharmaceuticals

Nereus Pharmaceuticals

TMT·US·Exited 2012
Entry
–
Hold
–
Exit
2012

Who owns Nereus Pharmaceuticals?

Nereus Pharmaceuticals was owned by Gimv, exited via Trade Sale.

Buyer identity available on Pro.

Hand-verified · updated 2026-04-21

Gimv
Investor
Gimv
Fund attribution unclassified.

Key facts

HQUnited States
SectorTMT
Exit Type
Trade Sale
Buyer
MOIC
–
Exit Year
2012

More from Gimv Portfolio

Other portfolio companies in the same fund.

Ablynx
Exited 2013
TMTBelgium
Acceo
Acceo
Active
TMTBelgium
Acertys Group
Exited 2015
TMTBelgium
to
ActoGeniX
Exited 2015
TMTBelgium
to
AgroBiothers
AgroBiothers
Active
TMTBelgium
Almaviva
Almaviva
Exited 2017
TMTBelgium
to

More PE-backed in TMT

Comparable tmt deals from other GPs.

3Bee
3Bee
Active
AgFunderUS
A+ Network
Active
Summit PartnersUS
A10 Networks
A10 Networks
Active
Summit PartnersUS
ABAX
ABAX
Active
InvestcorpNorway
ABC Fitness Solutions
ABC Fitness Solutions
Active
Thoma BravoUS
Acacia Communications
Acacia Communications
Active
Summit PartnersUS
Track Nereus Pharmaceuticals

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Get the full record on Nereus Pharmaceuticals.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue